Browsed by
Author: Member Success

Maryland’s only hospital-based bioincubator making inroads

Maryland’s only hospital-based bioincubator making inroads

Celebrating its five-year anniversary the LifeBridge Health Bioincubator has landed nearly $60 million in funding from 36 grants and received 36 patents. Serving as the state’s only hospital-based bioincubator, the facility has launched several companies with potentially groundbreaking technologies, including gene therapy for cystic fibrosis, an ingestible capsule for the early detection of esophageal cancer, and an ultrasound-enabled bedside feeding tube. ...  Read more

Celebrating 25 Years of Satellite Internet

Celebrating 25 Years of Satellite Internet

The world looked very different 25 years ago – Blockbuster Video was still king of movie rentals, the Palm Pilot had just been introduced to the world, and the launch of the first generation iPhone was still a decade away. The connectivity landscape was sparse, and the world wide web was still just a novelty, not the necessity it is today. It was also the time when Hughes invented satellite internet to help improve the dial-up experience. Since then, satellite internet has become a staple for millions of homes and businesses in rural locations and has grown to support email, social media, web browsing, videos and more. ...  Read more

United Therapeutics Announces FDA Approval of Tyvaso DPI™

United Therapeutics Announces FDA Approval of Tyvaso DPI™

First approval of a dry powder inhaler for treatment of PAH and PH-ILD

DPI device represents a convenient option for administration of treprostinil therapy

Commercial launch activities underway; patient availability expected in June 2022

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–May 24, 2022–United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the U.S. Food and Drug Administration (FDA) has approved Tyvaso DPI™ (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) and pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3) to improve exercise ability. Tyvaso DPI represents a new formulation and inhalation device for inhaled treprostinil and is the only dry powder inhaler approved by the FDA for use in PAH and PH-ILD. ...  Read more

TEDCO to Receive up to $50 Million from State Small Business Credit Initiative

TEDCO to Receive up to $50 Million from State Small Business Credit Initiative

COLUMBIA, Md. (May 25, 2022)—TEDCO, Maryland’s economic engine for technology companies, announced today it will receive up to $50 million from Governor Hogan’s small business relief plan that was approved for funding from the United States Treasury Department’s State Small Business Credit Initiative (SSBCI). TEDCO will allocate the funds into four existing programs targeting technology-based Maryland businesses and entrepreneurs. ...  Read more

Fzata Winner of Mid-Atlantic Innovation Celebration, Biotechnology

Fzata Winner of Mid-Atlantic Innovation Celebration, Biotechnology

Fzata, Inc., a biotech innovator, is proud to announce that it has been named the winner of the 2022 Mid-Atlantic Innovation Celebration for Biotechnology for its oral Bioengineered Probiotic Yeast Medicines (BioPYM™) platform. The Company is honored to have been selected for this award from among so many highly innovative competitors. ...  Read more